A phase 2, multicenter study to assess the efficacy and safety of autologous tumor-infiltrating lymphocytes (LN-144) for the treatment of patients with metastatic melanoma

Amod Sarnaik; Brendan D. Curti; Diwakar Davar; John M. Kirkwood; Omid Hamid; Jose Lutzky; Melissa Wilson; Harriet M. Kluger; Eric D. Whitman; Giao Q. Phan; Sajeve Samuel Thomas; Karl D. Lewis; Hendrik-Tobias Arkenau; Jason Alan Chesney; Bente Larsen; Igor Gorbatchevsky; Sam Suzuki; Nancy Louise Samberg; Maria Fardis

doi:10.1200/JCO.2018.36.15_suppl.TPS9595

Back

A phase 2, multicenter study to assess the efficacy and safety of autologous tumor-infiltrating lymphocytes (LN-144) for the treatment of patients with metastatic melanoma

Journal article

Peer reviewed

A phase 2, multicenter study to assess the efficacy and safety of autologous tumor-infiltrating lymphocytes (LN-144) for the treatment of patients with metastatic melanoma

Amod Sarnaik, Brendan D. Curti, Diwakar Davar, John M. Kirkwood, Omid Hamid, Jose Lutzky, Melissa Wilson, Harriet M. Kluger, Eric D. Whitman, Giao Q. Phan, …

Journal of clinical oncology, Vol.36(15_suppl), pp.TPS9595-TPS9595

2018-05-20

DOI: https://doi.org/10.1200/JCO.2018.36.15_suppl.TPS9595

Metrics

6 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.6 Immunology; 1.6.214 PD-1
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: A phase 2, multicenter study to assess the efficacy and safety of autologous tumor-infiltrating lymphocytes (LN-144) for the treatment of patients with metastatic melanoma
Creators: Amod Sarnaik - Moffitt Cancer Center
Brendan D. Curti - Providence Portland Medical Center
Diwakar Davar - University of Pittsburgh Medical Center
John M. Kirkwood - University of Pittsburgh Medical Center
Omid Hamid - Angeles Clinic and Research Institute
Jose Lutzky - Mount Sinai Medical Center
Melissa Wilson - New York University
Harriet M. Kluger - Yale Cancer Center
Eric D. Whitman - Atlantic Health System
Giao Q. Phan - Virginia Commonwealth University
Sajeve Samuel Thomas - University of Florida Health
Karl D. Lewis - University of Colorado Cancer Center
Hendrik-Tobias Arkenau - Sarah Cannon Research Institute
Jason Alan Chesney - University of Louisville
Bente Larsen - Theravance Biopharma
Igor Gorbatchevsky - Theravance Biopharma
Sam Suzuki - Theravance Biopharma
Nancy Louise Samberg - Theravance Biopharma
Maria Fardis - Theravance Biopharma
Publication Details: Journal of clinical oncology, Vol.36(15_suppl), pp.TPS9595-TPS9595
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757860602976